Mohammed M. Alruwaili

Employment

• Northern Border University Director of Center for Health Research
  2026 - Present
• Northern Border University Assistant Professor
  2025 - Present
• Northern Border University Lecturer
  2025 - 2025
• Roswell Park Comprehensive Cancer Center PhD Student
  2019 - 2025
• Nortern Border University Researcher
  2017 - 2019
• Yale University Postgraduate Fellow
  2017 - 2017
• Northen Border Uuiversity Researcher
  2014 - 2015

Education

• University at Buffalo PhD
  2019 - 2025
• Quinnipiac University M.Sc
  2015 - 2017
• Northern Border University B.Sc.
  2009 - 2013

Projects & Funding

Projects & funding information is unavailable.

Publications (24)

• Multi-omics profiling of oxeiptosis-associated biomarkers in cancer
  Abida Khan, Mohammed Alruwaili, Hayaa M. Alhuthali +5 more
  Clinica Chimica Acta 2027 DOI: 10.1016/j.cca.2026.121194
  +Save
• FHL1 Downregulation Is Specific to Cancer-Associated Fibroblasts and Linked to Reduced Chromatin Accessibility in Colorectal Cancer
  Genes 2026 DOI: 10.3390/genes17101210
  +Save
• Development and Optimization of Sodium Deoxycholate-Stabilised Shellac-Based Polymeric Nanoparticles for Enhanced Pharmacokinetics and Anticancer Activity of Etodolac in Hepatocellular Carcinoma
  Polymers 2026 DOI: 10.3390/polym18151863
  +Save
• Neoadjuvant PD-1-Based Immunotherapy in Localized dMMR/MSI-H Colorectal Cancer: A Systematic Review and Arm-Based Meta-Analysis
  Cancers 2026 DOI: 10.3390/cancers18152436
  +Save
• Hepatoprotective effects of empagliflozin in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of preclinical studies
  Frontiers in Pharmacology 2026 DOI: 10.3389/fphar.2026.1822157
  +Save
• Topical nano-chitosan mitigates alendronate-induced lingual mucosal injury in rats: histological, immunohistochemical, molecular, and ultrastructural study
  BMC Oral Health 2026 DOI: 10.1186/s12903-026-09249-8
  +Save
• Exploring the role of PARP9 expression in AML: prognostic implications and transcriptomic insights
  3 Biotech 2026 DOI: 10.1007/s13205-026-04768-1
  +Save
• Gasdermin proteins as pyroptosis-based biomarkers in ovarian cancer: Diagnostic and prognostic utility
  Mohammed Alruwaili, Mariam Shabram Alenazi, Howayada Mahany Mostafa +5 more
  Clinica Chimica Acta 2026 DOI: 10.1016/j.cca.2026.121152
  +Save
• Impact of adenotonsillectomy on asthma control in children: a systematic review and meta-analysis of clinical outcomes
  Journal of Asthma 2026 DOI: 10.1080/02770903.2025.2577638
  +Save
• Nicotine Pouches and Oral Mucosal Health: A Review of Cellular, Histopathological, and Potentially Malignant Changes
  European Journal of Prosthodontics and Restorative Dentistry 2026 DOI: 10.1922/EJPRD_2865Alanazi23
  +Save
• The ameliorative effects of propolis and/or levothyroxine on propylthiouracil-induced hypothyroidism in adult albino rats
  Journal of Radiation Research and Applied Sciences 2025 DOI: 10.1016/j.jrras.2025.102040
  +Save
• A Sequential Triple-Drug Strategy for Selective Targeting of p53-Mutant Cancers
  2025 DOI: 10.1101/2025.11.06.687028
  +Save
• BOGO: A Proteome-Wide Gene Overexpression Platform for Discovering Rational Cancer Combination Therapies
  2025 DOI: 10.1101/2025.09.02.673780
  +Save
• p38 blockade reverses the immune suppressive tumor microenvironment in metastatic breast cancer
  2025 DOI: 10.1101/2025.05.08.652949
  +Save
• Targeting p38αReprograms the Tumor Immune Microenvironme​nt to Inhibit Metastatic Breast Cancer­
  Ssrn 2025 DOI: 10.2139/ssrn.5668713
  +Save
• Using Fuzzy C-Means clustering and PCA in public health: A machine learning approach to combat CVD and obesity
  Informatics in Medicine Unlocked 2025 DOI: 10.1016/j.imu.2025.101666
  +Save
• p38 blockade reverses the immune suppressive tumor microenvironment in metastatic breast cancer
  Research Square 2025 DOI: 10.21203/rs.3.rs-7151795/v1
  +Save
• A synergistic two-drug therapy specifically targets a DNA repair dysregulation that occurs in p53-deficient colorectal and pancreatic cancers
  Cell Reports Medicine 2024 DOI: 10.1016/j.xcrm.2024.101434
  +Save
• A Synergistic Two-Drug Therapy Specifically Targets a DNA Repair Dysregulation That Occurs in p53-Deficient Colorectal and Pancreatic Cancers
  Ssrn 2023 DOI: 10.2139/ssrn.4412635
  +Save
• Camel Milk Exosomes Potentiate The Anticancer Effect of Doxorubicin on Multidrug-Resistant Human Leukemia Hl60 Cells in Vitro and in Vivo
  Pakistan Journal of Medical and Health Sciences 2021 DOI: 10.53350/pjmhs2115113313
  +Save